Role of Early API in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients

Superior University

Status: Active, not recruiting

Conditions: Dysplastic Nodule

Treatments: Diagnostic Test: assesment

Study type: Observational

Funder types: Other

Identifiers

NCT07080372

MSAHSW/Batch-Fall23/926

Details and patient eligibility

About

Liver cirrhosis is a common consequence of chronic liver disease, resulting from sustained hepatic injury due to various etiologies. Cirrhosis predisposes individuals to the development of hepatocellular carcinoma (HCC), the most prevalent primary malignancy of the liver. Among cirrhotic patients, distinguishing between hepatocellular carcinoma and dysplastic nodules is crucial for timely diagnosis, treatment planning, and prognostic assessment.

Enrollment: 73 patients

Sex: All

Ages: 5+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with abnormal LFTs
• Liver lesions of various sizes
• Patients with chronic liver disease
• Individuals undergoing routine liver screening
• Willing participants who consent to the study

Exclusion criteria

• Children less than 5years
• Patients who are allergic or have a history of allergy to contrast media
• Patients with deranged renal function tests
• Pregnant women